Serial Monitoring of Circulating Melanoma Cells During Neoadjuvant Biochemotherapy for Stage III Melanoma: Outcome Prediction in a Multicenter Trial

PURPOSE: Circulating tumor cells (CTCs) in blood may be important in assessing tumor progression and treatment response. We hypothesized that quantitative real-time reverse transcriptase polymerase chain reaction using multimarker mRNA assays could detect CTCs and be used as a surrogate predictor of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Koyanagi, Kazuo, O’Day, Steven J., Gonzalez, Rene, Lewis, Karl, Robinson, William A., Amatruda, Thomas T., Wang, He-Jing, Elashoff, Robert M., Takeuchi, Hiroya, Umetani, Naoyuki, Hoon, Dave S.B.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2005
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2856446/
https://ncbi.nlm.nih.gov/pubmed/16258104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2005.02.0958
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi